InvestorLens

NVCR — NOVOCURE LTD

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NVCR?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 1 selling last quarter
8
Macro Tailwind
Macro conditions are mixed for this sector
55
Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their NVCR position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Contraction regime).

Supporting evidence
  • +4 tracked investors reported holding NVCR at their latest filing
  • +Macro Health is 55/100 in a Contraction regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/17/2026.

About NOVOCURE LTD (NVCR)

NOVOCURE LTD (NVCR) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $35M. Across recent filings, tracked investors recorded 4 new positions, 5 increased, 3 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NVCR

56
/100
Mixed Activity
Added / Increased9
Reduced3
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track NVCR

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

NVCR Ownership Composition

How NOVOCURE LTD is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
84% of tracked value
Institutions
4
tracked investors
Total Reported
$26.1M
combined 13F value
Types2
  • Multi-Strategy / Quant84.4%
  • Macro15.6%
Multi-Strategy / Quant(3)
84.4%
Macro(1)
15.6%

Tracked investors currently reporting NVCR

3 tracked investors have since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    278.1K
    Value
    $4.2M
    % Portfolio
    0.00%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    373.7K
    Value
    $5.7M
    % Portfolio
    0.00%
  • Steve CohenJun 30, 2026
    Point72 Asset Management
    Shares
    803.1K
    Value
    $12.2M
    % Portfolio
    0.01%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    269K
    Value
    $4.1M
    % Portfolio
    0.01%

Previously held NVCR

These investors reported NVCR in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Philippe LaffontCoatue Management608.7K$10.8MMar 31, 2025
Howard MarksOaktree Capital Management4.3M$4.3MSep 30, 2025
Ray DalioBridgewater Associates39.4K$615.6KSep 30, 2024

Recent activity

Frequently asked questions

How many institutional investors hold NVCR?
4 tracked institutional investors disclosed a position in NVCR (NOVOCURE LTD) in their most recent 13F filing.
Who is the largest institutional holder of NVCR?
Izzy Englander, Millennium Management, holds the largest disclosed position in NVCR, valued at $35M.
Did institutional ownership of NVCR increase or decrease?
Across recent 13F filings, tracked investors recorded 4 new positions, 5 increased, 3 reduced, and 4 fully exited NVCR.
Where does this NVCR ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
NVCR (NOVOCURE LTD) — Institutional Holders & 13F History — InvestorLens